Endobronchial fiducial to guide stereotactic body radiotherapy.

Journal Article

Optimal treatment for unresectable central airway tumors is not well established. Stereotactic body radiation therapy has shown efficacy for both peripheral and central lung lesions. However, the treatment of central tumors has been limited because of associated radiation toxicity. We report the use of an endobronchial fiducial to localize hypofractionated stereotactic body radiation therapy treatment of a limited central airways disease in a patient with recurrent metastatic squamous cell lung cancer. The fiducial was instrumental in designing the treatment field and minimizing related treatment toxicity. Future studies may take advantage of this technique in patients with unresectable central airways non-small cell lung cancers.

Full Text

Duke Authors

Cited Authors

  • Shofer, SL; Dunphy, F; Mahmood, K; Wahidi, MM; Yoo, D

Published Date

  • July 2013

Published In

Volume / Issue

  • 20 / 3

Start / End Page

  • 274 - 275

PubMed ID

  • 23857206

Electronic International Standard Serial Number (EISSN)

  • 1948-8270

Digital Object Identifier (DOI)

  • 10.1097/LBR.0b013e31829dd690

Language

  • eng

Conference Location

  • United States